Class III β-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer
Lucas Maahs(Henry Ford Health System), Clara Hwang(Henry Ford Health System), Bertha E. Sanchez(Henry Ford Health System), Evelyn Barrack(Johns Hopkins University), Nilesh Gupta(Henry Ford Health System), Meredith Van Harn(Henry Ford Health System), Prem-veer Reddy(Henry Ford Hospital)
Cited by 24
Related Papers
Androgen receptor gene mutations in human prostate cancer.
|Proceedings of the National Academy of Sciences|1992|420
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
|Modern Pathology|2014|227
ERG gene rearrangements are common in prostatic small cell carcinomas
|Modern Pathology|2011|219